Browser-side verification
Verify Enrofloxacin
คุณไม่ต้องเชื่อ source.cuvetsmo.com — โค้ดด้านล่างทำงานในเครื่องของคุณ คำนวณ SHA-256 และ verify Ed25519 signature เทียบกับ public key ที่อาจารย์เซ็นต์รับเก็บไว้.
Signatures
0
Version
1
Status
pending
⏳ ยังไม่มี signature
Entry นี้ยังไม่ได้ลงนามโดย key ใดเลย — Phase 0 mirror snapshot ที่รอ Thai translation + faculty signoff. ดูสถานะการ review ที่ หน้า detail
Show the raw inputs (paranoid mode)
Drug JSON
This is exactly what your browser canonicalizes + SHA-256-hashes
{
"slug": "enrofloxacin",
"nameEn": "Enrofloxacin",
"nameTh": "เอนโรฟล็อกซาซิน",
"class": "Antibiotic — fluoroquinolone (bactericidal, veterinary)",
"mechanism": "ยาปฏิชีวนะกลุ่ม fluoroquinolone ออกฤทธิ์ฆ่าเชื้อโดยยับยั้ง DNA gyrase และ topoisomerase IV ทำให้แบคทีเรียจำลอง DNA ไม่ได้; ครอบคลุม gram-negative ได้ดี รวมถึง Pseudomonas",
"brandNamesTh": [
"Baytril",
"Enrocare"
],
"indications": [
{
"text": "ติดเชื้อแบคทีเรียที่ดื้อต่อยากลุ่มอื่น โดยเฉพาะ gram-negative รวม Pseudomonas; ใช้กับการติดเชื้อทางเดินปัสสาวะ ผิวหนัง ทางเดินหายใจ",
"cites": [
"elanco-baytril"
]
}
],
"contraindications": [
{
"text": "หลีกเลี่ยงในสัตว์เล็กที่กระดูกยังเจริญไม่เต็มที่ (เสี่ยงต่อความเสียหายของกระดูกอ่อนข้อต่อ/cartilage); ⚠️ ห้ามให้เกินขนาดในแมว (ดู side effects)",
"cites": [
"elanco-baytril"
]
}
],
"sideEffects": [
{
"text": "⚠️ ในแมว: เป็นพิษต่อจอประสาทตา (retinal degeneration) ทำให้ตาบอดเฉียบพลันได้ โดยเฉพาะเมื่อเกินขนาดสูงสุด 5 mg/kg/วัน; ขนาด ≥20 mg/kg ทำให้น้ำลายไหล อาเจียน ซึม และรอยโรคที่จอตา; อาการทั่วไป: GI upset",
"cites": [
"pubmed-enro-retina",
"elanco-baytril"
]
}
],
"dosages": [
{
"species": "canine",
"indication": "Bacterial infection",
"route": "PO",
"dose": "5–20 mg/kg ต่อวัน (เลือกตามความรุนแรงและความไวของเชื้อ)",
"cites": [
"elanco-baytril"
]
},
{
"species": "feline",
"indication": "Bacterial infection",
"route": "PO",
"dose": "5 mg/kg ต่อวัน — ⚠️ ห้ามเกิน 5 mg/kg/วัน (เสี่ยงจอประสาทตาเสื่อม/ตาบอด)",
"notes": "ขนาดสูงสุดในแมว 5 mg/kg/วันเด็ดขาด",
"cites": [
"elanco-baytril",
"pubmed-enro-retina"
]
}
],
"citations": [
{
"id": "elanco-baytril",
"type": "package-insert",
"title": "Baytril (enrofloxacin) — Elanco / FDA-approved label",
"year": 2025,
"url": "https://www.drugs.com/vet/baytril-enrofloxacin-antibacterial-tablets.html",
"note": "FDA-approved veterinary product label — canine 5–20 mg/kg/day, feline cap 5 mg/kg/day. Public FDA labeling.",
"cid": null
},
{
"id": "pubmed-enro-retina",
"type": "paper",
"title": "Enrofloxacin-associated retinal degeneration in cats",
"authors": "Gelatt KN, et al.",
"year": 2001,
"url": "https://pubmed.ncbi.nlm.nih.gov/11422990/",
"note": "Peer-reviewed evidence for feline retinotoxicity / blindness above 5 mg/kg/day. PubMed PMID 11422990.",
"cid": null
},
{
"id": "dailymed-enrofloxacin",
"type": "regulatory-database",
"title": "Enrofloxacin — NLM DailyMed (FDA Structured Product Labeling)",
"year": 2025,
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=enrofloxacin",
"note": "Cross-checked source: FDA-approved labeling. Search by name returns relevant product labelings.",
"cid": "ac9aa00c05958994b1bd682da41cbf39ae66590b1964a95403204668225df53f"
},
{
"id": "atc-J01MA90",
"type": "guideline",
"title": "ATC J01MA90 — Enrofloxacin",
"year": 2025,
"url": "https://www.whocc.no/atc_ddd_index/?code=J01MA90&showdescription=no",
"note": "Cross-checked source: WHO Collaborating Centre ATC/DDD index. Authoritative drug classification.",
"cid": "29a5aec4bb3a9629e0448bc1537c6e39de5a2045eeb9aa2b7e5341002ff1b2ff"
},
{
"id": "pubchem-enrofloxacin",
"type": "monograph",
"title": "Enrofloxacin — PubChem search",
"year": 2025,
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Enrofloxacin",
"note": "Cross-checked source: chemical structure, identifiers, pharmacology summary. Faculty review fills exact CID.",
"cid": "0449511aa4f33b867c2b37b9e650ca5a2159d676906e4a7b201dc6c8ff830c36"
},
{
"id": "wsava-amr-2023",
"type": "guideline",
"title": "WSAVA Therapeutic Guidelines Group — Library on Responsible Antimicrobial Use and AMR Prevention (2023)",
"year": 2023,
"url": "https://wsava.org/wp-content/uploads/2023/05/WSAVA-TGG-library-on-responsible-antimicrobial-use-and-AMR-prevention-2.pdf",
"note": "Cross-checked source: WSAVA TGG framework for prudent antibiotic use in companion animals (PDF, stable URL).",
"cid": "29f7ea6edf16004626349e036f3eb2ea30803ca1f6efd437bff0e8a4f2f465f1"
}
],
"mirroredFrom": [
{
"id": "dailymed",
"name": "NLM DailyMed",
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=enrofloxacin",
"asOfDate": "2026-05-27",
"license": "U.S. Government work — public domain. Attribution recommended."
},
{
"id": "atc",
"name": "WHO ATC Classification",
"url": "https://www.whocc.no/atc_ddd_index/?code=J01MA90&showdescription=no",
"asOfDate": "2026-05-27",
"license": "WHO publication, free for use with attribution"
},
{
"id": "pubchem",
"name": "PubChem (NIH/NLM)",
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Enrofloxacin",
"asOfDate": "2026-05-27",
"license": "NIH/NLM public domain"
},
{
"id": "wsava-amr",
"name": "WSAVA TGG — Key Documents on Responsible Antimicrobial Use and AMR Prevention",
"url": "https://wsava.org/wp-content/uploads/2023/05/WSAVA-TGG-library-on-responsible-antimicrobial-use-and-AMR-prevention-2.pdf",
"asOfDate": "2026-05-27",
"license": "Free for educational use with attribution"
}
],
"mirrorCIDs": [
{
"sourceId": "dailymed",
"cid": "ac9aa00c05958994b1bd682da41cbf39ae66590b1964a95403204668225df53f",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "atc",
"cid": "29a5aec4bb3a9629e0448bc1537c6e39de5a2045eeb9aa2b7e5341002ff1b2ff",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "pubchem",
"cid": "0449511aa4f33b867c2b37b9e650ca5a2159d676906e4a7b201dc6c8ff830c36",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "wsava-amr",
"cid": "29f7ea6edf16004626349e036f3eb2ea30803ca1f6efd437bff0e8a4f2f465f1",
"capturedAt": "2026-05-27",
"status": "stub"
}
],
"codes": {
"atc": {
"code": "J01MA90",
"name": "Enrofloxacin",
"level": 5
},
"rxnorm": {
"cui": "37617",
"name": "Enrofloxacin"
}
},
"drafting": {
"aiAssisted": false,
"aiModel": null,
"aiPromptHash": null,
"humanReviewer": "palmzamak2547",
"humanReviewedAt": "2026-05-27",
"humanEditsRatio": null
},
"signatures": [],
"reviewedBy": null,
"lastUpdated": "2026-05-27",
"version": 1,
"changelog": [
{
"version": 0,
"date": "2026-05-27",
"summary": "Seed entry — cross-checked from 4 authoritative sources (NLM DailyMed, WHO ATC Classification, PubChem (NIH/NLM), WSAVA TGG — Key Documents on Responsible Antimicrobial Use and AMR Prevention). ATC J01MA90 + RxNorm 37617. Thai translation + faculty review pending."
},
{
"version": 1,
"date": "2026-05-27",
"summary": "Clinical content compiled from cited sources — canine 5–20 mg/kg/day, feline hard cap 5 mg/kg/day with retinal-toxicity warning verified against FDA Baytril label + PubMed PMID 11422990. Every statement cited. Reviewed by palmzamak2547. Pending faculty canonical signature."
}
],
"interactions": [
{
"text": "ลดการดูดซึมเมื่อให้ร่วม cation (Ca/Mg/Al/Fe, sucralfate, antacid); เพิ่มระดับ theophylline",
"cites": [
"elanco-baytril"
]
}
],
"monitoring": [
{
"text": "ในแมวเฝ้าระวังการมองเห็น (รูม่านตาขยาย ชนสิ่งของ); หยุดยาทันทีหากสงสัยปัญหาตา",
"cites": [
"pubmed-enro-retina"
]
}
]
}Public keys used
[]